CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,005 enrolled
Drug / intervention
EMC2 Strategybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02785458
NCT02785458N/ACompleted
CompareCT.gov

Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

Northwestern University·interventional·Posted May 27, 2016·Updated Jan 27, 2021

In Brief

A clinical study evaluating EMC2 Strategy for High-risk Medications. Completed, enrolled 1,005 participants across 1 site.

Detailed Summary

This study evaluates the effectiveness of an electronic health record based educational intervention (the EMC2 strategy) to improve patient understanding and use of higher-risk medications. Half of the participants will receive the intervention, while the other half will receive the usual amount of information (usual care).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHigh-risk Medications
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Boston Medical Center, University of North Carolina, Chapel Hill, University of Illinois at Chicago

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 27, 2016
Enrollment StartJun 8, 2017
Primary CompletionSep 20, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.1 years ago

Interventions

EMC2 Strategybehavioral

The intervention includes 1) distribution of simplified one-page medication guide summaries, 2) an automated follow-up call to assess medication safety and problematic side effects and 3) summary reports of call to providers with any concerns flagged for clinic follow-up.